Your session is about to expire
← Back to Search
Hearing aids for Hearing Loss
N/A
Waitlist Available
Led By Jinyu Qian, PhD
Research Sponsored by Sonova AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 hours during 1 session
Awards & highlights
Study Summary
This trial is measuring oxygenation in the PFC of adults with hearing loss to see if hearing aid use can help.
Eligible Conditions
- Hearing Loss
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 hours during 1 session
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 hours during 1 session
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Listening effort
Speech-in-noise performance
Trial Design
1Treatment groups
Experimental Treatment
Group I: Participants with hearing loss.Experimental Treatment2 Interventions
Participants with hearing loss.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hearing aids
2021
N/A
~580
Find a Location
Who is running the clinical trial?
Sonova AGLead Sponsor
78 Previous Clinical Trials
1,837 Total Patients Enrolled
70 Trials studying Hearing Loss
1,643 Patients Enrolled for Hearing Loss
Toronto Metropolitan UniversityOTHER
84 Previous Clinical Trials
10,937 Total Patients Enrolled
2 Trials studying Hearing Loss
113 Patients Enrolled for Hearing Loss
Ryerson UniversityOTHER
76 Previous Clinical Trials
7,869 Total Patients Enrolled
1 Trials studying Hearing Loss
76 Patients Enrolled for Hearing Loss
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger